Pierre Jean Ousset

3.5k total citations · 2 hit papers
27 papers, 1.6k citations indexed

About

Pierre Jean Ousset is a scholar working on Psychiatry and Mental health, Physiology and Geriatrics and Gerontology. According to data from OpenAlex, Pierre Jean Ousset has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 12 papers in Physiology and 7 papers in Geriatrics and Gerontology. Recurrent topics in Pierre Jean Ousset's work include Dementia and Cognitive Impairment Research (18 papers), Frailty in Older Adults (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Pierre Jean Ousset is often cited by papers focused on Dementia and Cognitive Impairment Research (18 papers), Frailty in Older Adults (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Pierre Jean Ousset collaborates with scholars based in France, United States and Spain. Pierre Jean Ousset's co-authors include Sandrine Andrieu, Bruno Vellas, S. Gillette‐Guyonnet, Fati Nourhashémi, Matteo Cesari, Philippe Robert, Gabor Abellán van Kan, Marco Canevelli, J. Touchon and Yves Rolland and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Alzheimer s Disease and Alzheimer s & Dementia.

In The Last Decade

Pierre Jean Ousset

26 papers receiving 1.5k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) International Consensus Group

2013 725 citations Matteo Cesari, Marco Canevelli et al. The journal of nutrition health & aging profile →
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

2023 75 citations Linus Jönsson, Anders Wimo et al. The Lancet Regional Health - Europe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre Jean Ousset France	17	816	778	757	305	200	27	1.6k
Lindsay Wallace Canada	21	466 0.6×	708 0.9×	945 1.2×	481 1.6×	216 1.1×	44	1.5k
Béatrice Tavernier France	18	530 0.6×	835 1.1×	894 1.2×	385 1.3×	180 0.9×	21	2.1k
Sandrine Andrieu France	27	886 1.1×	962 1.2×	475 0.6×	180 0.6×	286 1.4×	64	2.2k
J. Fitten United States	10	529 0.6×	566 0.7×	618 0.8×	239 0.8×	111 0.6×	12	1.3k
Mei Sian Chong Singapore	27	765 0.9×	588 0.8×	403 0.5×	141 0.5×	231 1.2×	75	2.0k
Emma Reynish United Kingdom	23	1.1k 1.3×	616 0.8×	461 0.6×	192 0.6×	504 2.5×	47	2.3k
Marco Canevelli Italy	28	1.3k 1.6×	1.1k 1.4×	1.2k 1.6×	552 1.8×	307 1.5×	124	2.9k
Christelle Cantet France	31	1.2k 1.5×	857 1.1×	479 0.6×	283 0.9×	443 2.2×	87	2.4k
M. Soto France	12	492 0.6×	515 0.7×	707 0.9×	276 0.9×	124 0.6×	20	1.1k
Leandro Cascavilla Italy	18	370 0.5×	446 0.6×	380 0.5×	171 0.6×	130 0.7×	33	1.3k

Countries citing papers authored by Pierre Jean Ousset

Since Specialization

Citations

This map shows the geographic impact of Pierre Jean Ousset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Jean Ousset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Jean Ousset more than expected).

Fields of papers citing papers by Pierre Jean Ousset

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Jean Ousset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Jean Ousset. The network helps show where Pierre Jean Ousset may publish in the future.

Co-authorship network of co-authors of Pierre Jean Ousset

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Jean Ousset. A scholar is included among the top collaborators of Pierre Jean Ousset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Jean Ousset. Pierre Jean Ousset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jönsson, Linus, Anders Wimo, Ron Handels, et al.. (2023). The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. The Lancet Regional Health - Europe. 29. 100657–100657. 75 indexed citations breakdown →

Guyonnet, Sophie, Yves Rolland, Catherine Takeda, et al.. (2021). The INSPIRE Bio-Resource Research Platform for Healthy Aging and Geroscience: Focus on the Human Translational Research Cohort (The INSPIRE-T Cohort). The Journal of Frailty & Aging. 10(2). 110–120. 20 indexed citations

Barreto, Philipe de Souto, Kristell Pothier, Gaëlle Soriano, et al.. (2021). A Web-Based Multidomain Lifestyle Intervention for Older Adults: The eMIND Randomized Controlled Trial. The Journal of Prevention of Alzheimer s Disease. 8(2). 142–150. 35 indexed citations

Sourdet, Sandrine, Gaëlle Soriano, Julien Delrieu, et al.. (2021). Cognitive Function and Amyloid Marker in Frail Older Adults: The Cogfrail Cohort Study. The Journal of Frailty & Aging. 10(2). 160–167. 5 indexed citations

Soto, María, et al.. (2019). Potentially modifiable factors associated with agitation and aggression in Alzheimer’s disease: results of the ICTUS study. International Psychogeriatrics. 31(10). 1509–1516. 2 indexed citations

Touchon, Jacques, Pierre Jean Ousset, Florence Pasquier, et al.. (2017). [P2–005]: TREATMENT WITH PXT‐864 SHOWED STABILISATION OF COGNITIVE DISABILITY IN MILD ALZHEIMER's DISEASE AFTER 36 WEEKS. Alzheimer s & Dementia. 13(7S_Part_12). 1 indexed citations

Handels, Ron, Lisa Vermunt, Sietske A.M. Sikkes, et al.. (2017). [O5–03–01]: PREDICTING THE HEALTH ECONOMIC IMPACT OF EARLY TREATMENT IN PRE‐DEMENTIA ALZHEIMER's DISEASE. Alzheimer s & Dementia. 13(7S_Part_30). 1 indexed citations

Delrieu, Julien, Sandrine Andrieu, M. Pahor, et al.. (2016). NEUROPSYCHOLOGICAL PROFILE OF “COGNITIVE FRAILTY” SUBJECTS IN MAPT STUDY. The Journal of Prevention of Alzheimer s Disease. 3(3). 1–9. 67 indexed citations

Kiyasova, Vera, Hans‐Martin Schneble, Fabrice Bonneville, et al.. (2015). P1‐107: Longitudinal evaluation of clinical symptoms in controls, MCI, and Alzheimer's disease patients from the rosas study. Alzheimer s & Dementia. 11(7S_Part_8). 1 indexed citations

10.

Soto, María, Sandrine Andrieu, Fati Nourhashémi, et al.. (2014). Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design. International Psychogeriatrics. 27(2). 181–197. 32 indexed citations

11.

Ousset, Pierre Jean, Julien Delrieu, & Bruno Vellas. (2013). Should interventions to treat or prevent Alzheimer’s disease be tested in a population or as targeted treatment of highly selected study participants?. Alzheimer s Research & Therapy. 5(6). 62–62. 2 indexed citations

12.

Tavassoli, Néda, S. Gillette‐Guyonnet, Pierre Jean Ousset, et al.. (2012). Multidisciplinary team meetings (MDTM) in detection of Alzheimer's disease: Data from the idem study. The journal of nutrition health & aging. 17(2). 137–141. 6 indexed citations

13.

Houles, Mathieu, Marco Canevelli, Gabor Abellán van Kan, et al.. (2012). FRAILTY AND COGNITION. The Journal of Frailty & Aging. 1(2). 1–7. 19 indexed citations

14.

Villars, Hélène, C. Hein, Thierry Voisin, et al.. (2008). Maladie d'Alzheimer et syndromes apparentés au stade sévère.. Revue Neurologique. 164. 1 indexed citations

15.

Galluzzi, Samantha, Philip Scheltens, Laura van de Pol, et al.. (2008). Multi-Center Comparison of Medial Temporal Atrophy in Patients with Alzheimer’s Disease – Data from the ICTUS Study. Dementia and Geriatric Cognitive Disorders. 26(4). 314–322. 7 indexed citations

16.

Nourhashémi, Fati, Pierre Jean Ousset, Sophie Gillette‐Guyonnet, et al.. (2007). A 2‐year follow‐up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort). International Journal of Geriatric Psychiatry. 23(5). 460–465. 16 indexed citations

17.

Gregório, Pedro Gil, José Manuel Ribera Casado, Emma Reynish, et al.. (2005). The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey. International Journal of Geriatric Psychiatry. 20(8). 744–748. 32 indexed citations

18.

Andrieu, Sandrine, Emma Reynish, Fati Nourhashémi, et al.. (2002). Predictive factors of acute hospitalization in 134 patients with Alzheimer's disease: a one year prospective study. International Journal of Geriatric Psychiatry. 17(5). 422–426. 50 indexed citations

19.

Gillette‐Guyonnet, S., F. Nourhashémi, Sandrine Andrieu, et al.. (2000). Weight loss in Alzheimer disease. American Journal of Clinical Nutrition. 71(2). 637S–642S. 198 indexed citations

20.

Nourhashémi, Fati, S. Gillette‐Guyonnet, Sandrine Andrieu, et al.. (2000). Alzheimer disease: protective factors. American Journal of Clinical Nutrition. 71(2). 643S–649S. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact